or
forgot password

    • cancer clinical trials in lexington, KY

    • A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
    University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536
    Squamous Cell Carcinoma of the Head and Neck
    Study of Recombinant Human Thrombin for Bleeding During Surgery
    Bluegrass Orthopedics/Bluegrass Musculoskeletal Research
    Lexington, Kentucky 40509
    Surgical Hemostasis
    Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
    Markey Cancer Center
    Lexington, Kentucky 40536
    Stage IV Non-small Cell Lung Cancer, Stage IIIB-pleural Effusion
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Neuroblastoma
    A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
    University of Kentucky, Markey Cancer Center
    Lexington, Kentucky 40536-0093
    Acute Myelogenous Leukemia
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Head and Neck Cancer
    A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Non-Small Cell Lung Cancer
    High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Sarcoma
    Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Small Cell Lung Cancer
    Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Human Papillomavirus Type-16/-18 Infection, Papillomavirus Vaccines, Cervical Neoplasia
    Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Non-small Cell Lung Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    University of Kentucky
    Lexington, Kentucky 40536-0098
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Acute Myelogenous Leukemia
    A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
    AOI Pharmaceuticals Investigative Site
    Lexington, Kentucky 40536
    Glioma, Astrocytoma, Oligodendroglioma, Oligoastrocytoma
    Evaluating Patients With Varying Degrees of Renal Function
    University of Kentucky/Division of Hematology/Oncology and Blood Marrow Transplantation
    Lexington, Kentucky 40536
    Renal Impairment
    Evaluating Patients With Impaired Hepatic Function
    University of Kentucky/Division of Hematology/Oncology and Blood Marrow Transplantation
    Lexington, Kentucky 40536
    Impaired Hepatic Function
    Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
    AOI Pharmaceuticals Investigative Site
    Lexington, Kentucky 40536
    Colon Cancer
    Depression Screening in Patients With Lung Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Depression, Lung Cancer
    A Study of Abatacept in Patients With Active Crohn's Disease
    University of Kentucky Medical Center
    Lexington, Kentucky 40536-0093
    Crohn's Disease
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536
    Cytomegalovirus Infections
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    New Lexington Clinic, P.S.C.
    Lexington, Kentucky 40504
    Atrial Fibrillation, Atrial Flutter
    A Study for Patients With Head and Neck Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Head and Neck Neoplasms
    Assess Cancer in Ovarian Tumors With Biomarkers.
    University of Kentucky - Whitney Facility
    Lexington, Kentucky 40356-0084
    Ovarian Tumor
    A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumor
    An Study of Patients With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Patients Who Take R-CHOP Only
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Lymphoma
    Treatment of Oral Warts in HIV+ Patients
    University of Kentucky College of Dentistry
    Lexington, Kentucky 40536-0297
    Papillomatosis, HIV Infections
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Sarcoma
    A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Diffuse Large B-cell Lymphoma
    A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Prostate Cancer
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia
    Chemoprevention of Colorectal Adenomas
    University of Kentucky Medical Center
    Lexington, Kentucky 40536-0093
    Adenomatous Polyps
    A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Sarcoma, Soft Tissue
    An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Lung Neoplasms
    Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Head and Neck Cancer, Precancerous Condition
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    Associates in Neurology, PSC
    Lexington, Kentucky
    Multiple Sclerosis, Relapsing-Remitting
    Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Human Papillomavirus (HPV) Infection, Papillomavirus Vaccines
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Associates in Neurology, PSC
    Lexington, Kentucky
    Multiple Sclerosis, Relapsing-Remitting
    G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lung Cancer
    A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)
    Pain Treatment Center of the Bluegrass
    Lexington, Kentucky 40503
    Opioid Induced Constipation (OIC)
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site #214

    Trial Locations
    BioSante Site #214
    Biosante Site #136
    Hypoactive Sexual Desire Disorder
    Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
    University of Kentucky-Markey Cancer Center Clinical Research Organization
    Lexington, Kentucky 40536
    MDS, AML, Solid Tumors, Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease
    Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Non-Small Cell Lung Cancer
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Unspecified Childhood Solid Tumor, Protocol Specific
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Sarcoma
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    University of Kentucky Medical Center
    Lexington, Kentucky 40536-0093
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    University of Kentucky Medical Center
    Lexington, Kentucky 40536-0093
    Ulcerative Colitis
    Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
    Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
    University of Kentucky Hemophilia Treatment Center
    Lexington, Kentucky 40536-0284
    Von Willebrand Disease
    Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Non-small Cell Lung Cancer
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia
    SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lymphoma
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Bone Graft Materials Observational Registry
    Bluegrass Orthopedics & Hand Care Research
    Lexington, Kentucky 40509
    Degenerative Disc Disease, Herniated Disc, Spinal Stenosis, Spondylolithesis, Spinal Deformity, Cervical Myelopathy, Failed Back Surgery Syndrome, Spinal Cord Neoplasms
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lymphoma
    A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Melanoma
    S0916, MLN1202 in Treating Patients With Bone Metastases
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific